Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

FDA Issues Warning Over Misuse of Ketamine Therapy

Unsupervised treatment — fueled by telemedicine prescriptions — for various psychiatric problems poses a number of health risks, the agency said.

Andrew Jacobs
Author: Andrew Jacobs

Written by

Andrew Jacobs

in

Drugs (Pharmaceuticals), Food and Drug Administration, Ketamine (Drug), Mental Health and Disorders, Post-Traumatic Stress Disorder, Regulation and Deregulation of Industry, Telemedicine
←Supreme Court Conservatives Seem Likely To Accept South Carolina’s Racial Gerrymander
Marjorie Taylor Greene’s Disturbing Reason For Not Backing Steve Scalise As Speaker→

More posts

  • Protesters, leaders push back against DHS over Newark detention facility conditions

  • Goldman and Lander spar hard over Israel

  • Snowflake climbs after Q1 results top expectations, guidance gets a boost

  • Synopsys drops despite better than expected Q2 results, big boost to full-year guidance

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube